August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS32
Academic Journal
Presents an abstract of the research manuscript `Cyclosporine-induced leukoencephalopathy complicating bone marrow transplantation,' by A.S. Daly, L. Lacroix et al from the Montreal General Hospital.


Related Articles

  • Central neurotoxicity of cyclosporine in two children with nephrotic syndrome. Peudenier, Sylviane; Rambeau, Marc; Gandemer, Virginie; Bridoux, Laure; Bétrémieux, Pierre; Taque, Sophie; Gie, Sophie; De Parscau, Loic; Le Gall, Edouard // Pediatric Nephrology;Mar2004, Vol. 19 Issue 3, p276 

    The central neurotoxicity of cyclosporin A (CsA) has been abundantly documented in pediatric and adult recipients of bone marrow or organ transplants, with variations in the rate of occurrence from 0.5% to 35%. We report two cases of central neurotoxicity ascribable to CsA in children with...

  • Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Kolb, H.J.; Socie, Gerard; Socié, G; Duell, T; Van Lint, M T; Tichelli, A; Apperley, J F; Nekolla, E; Ljungman, P; Jacobsen, N; van Weel, M; Wick, R; Weiss, M; Prentice, H G // Annals of Internal Medicine;11/16/99, Vol. 131 Issue 10, p738 

    Background: Patients who receive bone marrow transplants have increased risk for new malignant conditions because of several risk factors, including conditioning with radiation and chemotherapy, immune stimulation, and malignant primary disease. The occurrence of and risk factors...

  • Conjunctival carcinoma as a novel post-stem cell transplantation malignancy. Hon, C; Au, WY; Liang, RHS // Bone Marrow Transplantation;Jul2004, Vol. 34 Issue 2, p181 

    A 46-year-old Chinese male nonsmoker with CML underwent allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling in 1995 after busulfancyclophosphamide conditioning. He developed moderate chronic GVHD of the mouth and skin and cyclosporin was tapered off after 2 years. He was...

  • Life-threatening neurological complications after bone marrow transplantation in children. Uckan, D; Cetin, M; Yigitkanli, I; Tezcan, I; Tuncer, M; Karasimav, D; Oguz, K K; Topçu, M // Bone Marrow Transplantation;Jan2005, Vol. 35 Issue 1, p71 

    Summary:Neurological complications may occur in BMT recipients (11-59%), frequently contributing to morbidity or mortality. They are the main causes of death in 10-15%. Life-threatening neurological complications were seen in 11 out of 113 (9.7%) children who underwent BMT from HLA-matched...

  • Ciclosporin.  // Reactions Weekly;3/31/2007, Issue 1145, p8 

    Case studies of two patients who developed pseudotumour cerebri are presented. Both patients developed pseudotumour cerebri after being treated for graft-versus-hose disease (GVHD) prophylaxis with ciclosporin. The patients underwent bone marrow transplantation. One patient is a 15-year-old girl...

  • Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin. Hayden, P. J.; Gardiner, N.; Molloy, K.; Ryan, J.; Lawler, M.; McCann, S. R. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p459 

    Presents a study that examined pure red cell aplasia (PRCA) following a major ABO-incompatible bone marrow transplant for chronic myeloid leukemia. Immunohematological complications of bone marrow transplantation in the setting of incompatibility between donor ABO antigens and the recipient...

  • Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy. Mackall, Crystal L.; Fleisher, Thomas A.; Brown, Margaret R.; Andrich, Mary P.; Chen, Clara C.; Feuerstein, Irwin M.; Horowitz, Marc E.; Magrath, Ian T.; Shad, Aziza T.; Steinberg, Seth M.; Wexler, Leonard H.; Gress, Ronald E. // New England Journal of Medicine;1/19/95, Vol. 332 Issue 3, p143 

    Background: Inadequate reconstitution of CD4+ T lymphocytes is an important clinical problem complicating chemotherapy, human immunodeficiency virus infection, and bone marrow transplantation, but relatively little is known about how CD4+ T lymphocytes regenerate. There are two main...

  • Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing... Lenssen, Polly; Bruemmer, Barbara A.; Bowden, Raleigh A.; Gooley, Ted; Aker, Saundra N.; Mattson, Debra // American Journal of Clinical Nutrition;May98, Vol. 67 Issue 5, p927 

    Presents information on a study which investigates the association between intravenous lipid dose and bacterial and fungal infections when patients undergo allogenic or autologous bone marrow transplants. Reference to a prospective trial carried out in patients with hematologic malignancies;...

  • Tracheobronchomalacia after allogeneic BMT; pulmonary function test findings similar to those of bronchiolitis obliterans. Watanabe, J; Sato, K; Fujikura, Y; Horiuchi, T; Kato, S; Hikota, R; Maekawa, T; Yamamura, T; Kobayashi, A; Kobayashi, S; Kawana, A; Kimura, F // Bone Marrow Transplantation;Nov2014, Vol. 49 Issue 11, p1450 

    A letter to the editor is presented which reports a case of tracheobronchomalacia following allogeneic bone marrow transplantation (BMT).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics